ritanserin has been researched along with Idiopathic Parkinson Disease in 3 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, S | 1 |
Zhang, QJ | 1 |
Liu, J | 1 |
Ali, U | 1 |
Wu, ZH | 1 |
Chen, L | 1 |
Gui, ZH | 1 |
Wang, Y | 1 |
Hui, YP | 1 |
Henderson, J | 1 |
Yiannikas, C | 1 |
Graham, JS | 1 |
Maertens de Noordhout, A | 1 |
Delwaide, PJ | 1 |
3 other studies available for ritanserin and Idiopathic Parkinson Disease
Article | Year |
---|---|
In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.
Topics: Action Potentials; Amphetamines; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; | 2009 |
Effect of ritanserin, a highly selective 5-HT2 receptor antagonist, on Parkinson's disease.
Topics: Aged; Female; Gait; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Ritanserin; Seroto | 1992 |
Open pilot trial of ritanserin in parkinsonism.
Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Pilot Pro | 1986 |